GRAS Notices
-
GRN No. 1055
Xylanase enzyme preparation produced by Bacillus licheniformis strain expressing the xylanase gene from Chryseobacterium
| Intended Use: | Intended for use as an enzyme at up to 68.5 mg Total Organic Solids (TOS)/kg raw material in grain processing, brewing, and manufacture of cereal-based beverages. |
|---|---|
| Basis: | Scientific procedures |
| Notifier: | Novozymes North America Inc. |
| Notifier Address: |
77 Perrys Chapel Church Road Franklinton, NC 27525 |
| GRAS Notice (releasable information): | GRN 1055 with Amendments (in PDF) (3.0 MB) |
| Date of closure: | Apr 4, 2023 |
| FDA's Letter: | FDA Has No Questions (in PDF) (265 kB) |
-
